A ‘Gutsy’ Approach to Predict Immunotherapy Responses
Researchers developed a model that uses the gut microbiome to predict if a patient's tumor would have a response...
Researchers developed a model that uses the gut microbiome to predict if a patient's tumor would have a response...
The FDA issued 18 oncology-related approvals in Q2 2024 including two first-in-class drugs and a bispecific T-cell engager for...
Learn about cancer vaccines, including the various types used to treat or prevent cancer, and discover what's on the...
Learn about the types of cancer immunotherapy including immune checkpoint inhibitors, ACT, therapeutic vaccines, and more.
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
This Trojan horse-like treatment strategy may help neutralize undruggable cancer drivers.
As the spring weather encourages the planting of flowers, vegetables, and herbs, even careful gardeners may see weeds creeping...
The year 2022 will be remembered as the time when the emergency phase of the COVID-19 pandemic began to...
For the sixth time since 2015, researchers, clinicians, drug developers, patient advocates, and other stakeholders convened at the International...